Dashboard
1
With ROE of 2.87%, it has a Very Expensive valuation with a 0.93 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -19.48%, its profits have fallen by -72.4%
2
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.03%
0%
-7.03%
6 Months
-17.69%
0%
-17.69%
1 Year
-19.48%
0%
-19.48%
2 Years
-51.26%
0%
-51.26%
3 Years
-48.56%
0%
-48.56%
4 Years
-58.29%
0%
-58.29%
5 Years
-48.27%
0%
-48.27%
Ramsay Générale de Santé SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.51%
EBIT Growth (5y)
-16.81%
EBIT to Interest (avg)
5.18
Debt to EBITDA (avg)
2.87
Net Debt to Equity (avg)
1.79
Sales to Capital Employed (avg)
0.52
Tax Ratio
56.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.79%
ROE (avg)
14.46%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
0.93
EV to EBIT
29.85
EV to EBITDA
13.95
EV to Capital Employed
0.97
EV to Sales
1.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.25%
ROE (Latest)
2.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'14 - YoY
Dec'14
Dec'13
Change(%)
Net Sales
448.50
470.60
-4.70%
Operating Profit (PBDIT) excl Other Income
55.60
56.30
-1.24%
Interest
5.00
9.00
-44.44%
Exceptional Items
-6.80
0.00
Consolidate Net Profit
-5.10
84.00
-106.07%
Operating Profit Margin (Excl OI)
61.10%
55.50%
0.56%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2014 is -4.70% vs -3.43% in Dec 2013
Consolidated Net Profit
YoY Growth in quarter ended Dec 2014 is -106.07% vs 531.58% in Dec 2013
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
5,242.00
5,006.50
4.70%
Operating Profit (PBDIT) excl Other Income
621.40
605.90
2.56%
Interest
214.80
205.40
4.58%
Exceptional Items
0.00
-39.70
100.00%
Consolidate Net Profit
-35.00
-36.70
4.63%
Operating Profit Margin (Excl OI)
35.70%
35.80%
-0.01%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 4.70% vs 6.49% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 4.63% vs -157.43% in Jun 2024
About Ramsay Générale de Santé SA 
Ramsay Générale de Santé SA
Pharmaceuticals & Biotechnology
Ramsay Generale de Sante SA, formerly Generale de Sante SA (GDS), is a France-based company engaged in the provision of private hospital healthcare services. The Company offers a range of hospital services and, in partnership with independent medical specialists, delivers a spectrum of care services, including oncology and radiation therapy; care for alcohol abuse and obesity; rehabilitation, such as cardiac rehabilitation and orthopedic and neurological reeducation, and diagnostics, such as medical imaging and analysis. In addition, the Company develops a care package, offering care with personal support, before, during and after hospitalization. The Company operates approximately 75 centers and institutions in France. The Company operates through a number of subsidiaries, such as HPM Hopital Prive Metropole SAS. Ramsay Health Care (UK) Ltd is the major shareholder of the Company.
Company Coordinates 
Company Details
39 Rue Mstislav Rostropovitch , PARIS None : 75017
Registrar Details






